Hindustan Zinc Ltd (HZL) has been fined ₹ 5.37 lakh each by the Bombay Stock Exchange (BSE) and the National Stock Exchange ...

On Wednesday, 3018 stocks advanced, 1033 declined and 115 remained unchanged, with an advance decline ratio of 2.92 on the ...

Zydus Lifesciences rose 3% to an intra-day high of Rs 930 after the company received approval from the US FDA to manufacture Apalutamide Tablets, 60 mg. However, the stock came off highs to trade 0.9% ...

Marksans Pharma Limited has announced that its wholly owned subsidiary Relonchem Limited has received Marketing Authorization ...

Shares of firms like Bajaj Auto, Airtel, Hindustan Zinc, LIC, NTPC, L&T, and others will be in focus on Wednesday's trade ...

As per the IQVIA MAT January 2025 data, apalutamide tablets registered annual sales of $1099.80 million in the United States ...

The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug ...

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...

Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Apalutamide tablets, 60 mg.

On March 18, post-market hours, Zydus Lifesciences announced that it has received approval from the United States Food & Drug ...

The positive trends at GIFT Nifty futures indicate a gap-up opening for Indian equity benchmarks Sensex and Nifty.

Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30  at 1:00 PM when the company ...